Reoperation for bleeding in patients undergoing coronary artery bypass surgery: Incidence, risk factors, time trends, and outcomes

Circulation: Cardiovascular Quality and Outcomes

Volumn 2, Issue 6, 2009, Pages 583-590

  Mehta, Rajendra H ^a   Sheng, Shubin ^a   O'Brien, Sean M ^a   Grover, Frederick L ^b   Gammie, James S ^c   Ferguson, T Bruce ^d   Peterson, Eric D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Bleeding; Bypass; Coronary disease; Outcomes; Reoperation

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURGICAL MORTALITY; TREATMENT OUTCOME; AGE; ARTIFICIAL VENTILATION; BODY MASS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; FACTUAL DATABASE; HEART DISEASE; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PNEUMONIA; SEPSIS; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; STROKE; TIME; UNITED STATES; UTILIZATION REVIEW;

ANTITHROMBOCYTIC AGENT;

AGE FACTORS; AGED; BODY MASS INDEX; COMORBIDITY; CORONARY ARTERY BYPASS; DATABASES, FACTUAL; FEMALE; HEART DISEASES; HEMORRHAGE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; PNEUMONIA; REOPERATION; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; RISK FACTORS; SEPSIS; SEX FACTORS; STROKE; TIME FACTORS; UNITED STATES;

EID: 77649202241     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.109.858811     Document Type: Article

References (25)

1. Unsworth-White MJ, Herriot A, Valencia O, Poloniecki J, Smith EEJ, Murday AJ, Parker DJ, Treasure T. Resternotomy for bleeding after cardiac operations: A marker for increased morbidity and mortality. Ann Thorac Surg. 1995;59:664-667.
2. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg. 1996;111:1037-1046. (Pubitemid 26146058)
3. Sellman M, Intonti MA, Ivert T. Reoperations for bleeding after coronary artery bypass procedures during 25 years. Eur J Cardiothorac Surg. 1997;11:521-527.
4. Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, Quinn RD, Nugent WC, Birkmeyer JD, O'Connor GT; for the Northern New England Cardiovascular Disease Study Group. Reoperation for hemorrhage following coronary artery bypass grafting-Incidence and risk factors. Arch Surg 1998;133:442-447.
5. Frankel TJ, Stamou SC, Lowery RC, Kapetanakis EI, Hill PC, Haile E, Corso PJ. Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass. J Cardiothorac Surg. 2005;27:494-500.
6. Munoz JJ, Birkemeyer NJO, Dacey LJ, Birkmeyer JD, Charlesworth DC, Johnson ER, Lahey SJ, Norotsky M, Quinn RD, Westbrook BM, O'Connor GT, for the Northern New England Cardiovascular Disease Study Group. Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery. Ann Thorac Surg. 1999;68:1321-1325.
7. Choong CK, Gerrard C, Goldsmith KA, Dunningham H, Vuylsteke A. Delayed re-exploration for bleeding after coronary artery bypass surgeryresults in adverse outcomes. Eur J CardioThorac Surg. 2007;31: 834-838.
8. Despotis GJ, Filos KS, Zoys TN, Hogue CW, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82:13-21.
9. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: Risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004;78: 527-534.
10. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel in patients undergoing surgical revascularization for Non-ST elevation acute coronary syndromes; The Clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial. Circulation. 2004;110: 1202-1208.
11. Kapetanakis EI, Medlam DA, Petro KR, Haile E, Hill PC, Dullum MK, Bafi AS, Boyce SW, Corso PJ. Effect of clopidogrel premedication in off-pump cardiac surgery: Are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation. 2006;113:1667-1674.
12. Kapetanakis EI, Mediam DA, Boyce SW, Haile E, Hill PC, Dullum MKC, Bafi AS, Petro KR, Corso PJ. Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache? Eur Heart J. 2005;26:576-583.
13. Edwards FH, Petersen ED, Coombs LP, DeLong ER, Jamieson WRE, Shroyer ALW, Grover FL. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885-892.
14. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856-1864.
15. Ferguson TB, Hamill PG, Peterson ED, DeLong ER, Glover FL. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg. 2002;73:480-490.
16. Plume SK, O'Connor GT, Omstead EM. Changes in patients undergoing coronary artery bypass grafting:1987-1990: Update in 2000. Ann Thorac Surg. 2001;72:314-315.
17. Janssens M, Hartstein G, David JL. Reduction in requirements for allogenic blood products: Pharmacologic methods. Ann Thorac Surg. 1996;62:1944-1950.
18. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. Duration of red blood cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229-1239.
19. Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol. 1990;15:15-20.
20. Sun JC, Whitlock R, Cheng J, Eikelboom JW, Thabane L, Crowther MA, Teoh KH. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: A systematic review of randomized and observational studies. Eur Heart J. 2008;29:1057-1571.
21. Angiolillo DJ, Guzzman LA. Clinical overview of promising nonthienopyridine antiplatelet agents. Am Heart J. 2008;156:S23-S28.
22. Angiolillo DJ. ADP receptor antagonism: What's in the pipeline? Am J Cardiovasc Drugs. 2007;7:423-432.
23. Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation. 2008;117:2865-2874.
24. Mehta RH, Chen AY, Pollack CV, Roe MT, Zalenski R, Delgado G, Gibler WB, Ohman EM, Harrington RA, Peterson ED. Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST elevation acute coronary syndromes. Am J Cardiol. 2006;98:624-627.
25. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA. 2002;288:2411-2420.